Raab & Moskowitz Asset Management »

Biomarin Pharmaceutical shares owned by Raab & Moskowitz Asset Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Raab & Moskowitz Asset Management from 13F filings

Historical chart of Raab & Moskowitz Asset Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Raab & Moskowitz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Raab & Moskowitz Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $31k 30k 1.03
2023-09-30 $30k 30k 0.99
2023-06-30 $30k 30k 1.01
2023-03-31 $31k 30k 1.04
2022-12-31 $33k 30k 1.09
2022-09-30 $30k 30k 1.00
2022-06-30 $30k 30k 1.00